Literature DB >> 19833781

Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children.

Pallaval V Bramhachari1, Santosh Y Kaul2,3, David J McMillan4,2, Melkote S Shaila1, Mohan G Karmarkar3, Kadaba S Sriprakash4,2.   

Abstract

Streptococcus pyogenes [group A streptococcus (GAS)], a human pathogen, and Streptococcus dysgalactiae subsp. equisimilis [human group G and C streptococcus (GGS/GCS)] are evolutionarily related, share the same tissue niche in humans, exchange genetic material, share up to half of their virulence-associated genes and cause a similar spectrum of diseases. Yet, GGS/GCS is often considered as a commensal bacterium and its role in streptococcal disease burden is under-recognized. While reports of the recovery of GGS/GCS from normally sterile sites are increasing, studies describing GGS/GCS throat colonization rates relative to GAS in the same population are very few. This study was carried out in India where the burden of streptococcal diseases, including rheumatic fever and rheumatic heart disease, is high. As part of a surveillance study, throat swabs were taken from 1504 children attending 7 municipal schools in Mumbai, India, during 2006-2008. GAS and GGS/GCS were identified on the basis of beta-haemolytic activity, carbohydrate group and PYR test, and were subsequently typed. The GGS/GCS carriage rate (166/1504, 11 %) was eightfold higher than the GAS carriage (22/1504, 1.5 %) rate in this population. The 166 GGS/GCS isolates collected represented 21 different emm types (molecular types), and the 22 GAS isolates represented 15 different emm types. Although the rate of pharyngitis associated with GGS/GCS is marginally lower than with GAS, high rates of throat colonization by GGS/GCS underscore its importance in the pathogenesis of pharyngitis.

Entities:  

Mesh:

Year:  2009        PMID: 19833781     DOI: 10.1099/jmm.0.015644-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  23 in total

1.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Molecular markers for discriminating Streptococcus pyogenes and S. dysgalactiae subspecies equisimilis.

Authors:  D J McMillan; T Vu; P V Bramhachari; S Y Kaul; A Bouvet; M S Shaila; M G Karmarkar; K S Sriprakash
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 3.267

4.  Seropositivity for Antibodies to DRS-G, a Virulence Factor from Streptococcus dysgalactiae subsp. equisimilis, Is an Independent Risk Factor for Poststreptococcus Glomerulonephritis and Chronic Kidney Disease in Mumbai, India.

Authors:  Gouri P Hule; Mohan G Karmarkar; Ainslie Cameron; Niwrutti Hase; Uday Khopkar; Preeti R Mehta; Celia L McNeilly; David McMillan; Kadaba S Sriprakash
Journal:  Clin Vaccine Immunol       Date:  2015-06-17

5.  Prevalence and molecular diversity of invasive Streptococcus dysgalactiae and Streptococcus pyogenes in a German tertiary care medical centre.

Authors:  S Rößler; R Berner; E Jacobs; N Toepfner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-03       Impact factor: 3.267

6.  Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination.

Authors:  David J McMillan; Debra E Bessen; Marcos Pinho; Candace Ford; Gerod S Hall; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

7.  Streptococcal group A, C and G pharyngitis in school children: a prospective cohort study in Southern India.

Authors:  J John Melbin Jose; Kootallur N Brahmadathan; Vinod J Abraham; Chiung-Yu Huang; David Morens; Nancy P Hoe; Dean A Follmann; Richard M Krause
Journal:  Epidemiol Infect       Date:  2018-04-04       Impact factor: 2.451

8.  Streptococcal surface proteins activate the contact system and control its antibacterial activity.

Authors:  Kristofer Wollein Waldetoft; Lisbeth Svensson; Matthias Mörgelin; Anders I Olin; D Patric Nitsche-Schmitz; Lars Björck; Inga-Maria Frick
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

9.  Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS).

Authors:  Yumi Shimomura; Kayo Okumura; Somay Yamagata Murayama; Junji Yagi; Kimiko Ubukata; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

10.  Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney disease.

Authors:  Mohan Ganesh Karmarkar; Gouri Pandharinath Hule; Niwrutti Khandu Hase; Preeti Rajeev Mehta; Scott Robert Walter; Kadaba Srinivasa Sriprakash
Journal:  BMC Nephrol       Date:  2013-05-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.